JP2002255604A - Calcium phosphate cement for bone reinforcing treatment capable of forming high strength hardened body - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a calcium phosphate cement for bone reinforcing treatment capable of forming a high strength hardened body. SOLUTION: The calcium phosphate cement for the bone reinforcing treatment is constituted of a mixed composition having a formulation composition consisting of 0.03-1.5% magnesium phosphate, 3-25% calcium secondary phosphate and the remainder of α-type calcium tertiary phosphate and inevitable impurities on the basis of mass%.

Description

DETAILED DESCRIPTION OF THE INVENTION

[0001]

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a calcium phosphate cement which can be used for augmentation of a living body in the field of medicine including oral surgery and can form a high-strength hardened body.

[0002]

2. Description of the Related Art Generally, a cement for living bone augmentation treatment includes (1) a setting property in which a slurry obtained by adding an aqueous solution for hardening is solidified, and (2) a setting property in which a solidified substance hardens in the presence of moisture. It is required that the cured body has properties such as (3) strength of the cured body sufficient to enable the movement of the treatment reinforcing bone, and (4) absorption and replacement properties of the cured body to be regenerated into living bone. As a cement having characteristics, various types of cement for augmenting and treating a living body have been proposed.

[0003]

On the other hand, since the hardened body is a foreign substance to the living body, it is desirable that a predetermined amount of strength can be obtained in the treatment reinforcing bone with the use of the hardened body as little as possible. In living bone augmentation treatment cement, because hardened body does not have sufficient high strength,
It has not been possible to satisfactorily reduce the amount of the hardened body used as a treatment reinforcing bone, and therefore there is a strong demand for the development of a cement for living body augmentation treatment capable of further improving the strength of the hardened body.

[0004]

Means for Solving the Problems Accordingly, the present inventors have:
In view of the above, as a result of conducting research to develop a living bone augmentation treatment cement capable of improving the strength of the cured body, calcium phosphate cement among various conventionally proposed biological bone augmentation treatment cements, that is, In mass% (hereinafter,% indicates mass%), dibasic calcium phosphate: 3 to
25%, α-type tribasic calcium phosphate and unavoidable impurities: specified as a calcium phosphate cement composed of a mixed composition having the remaining composition, and magnesium phosphate was added to the calcium phosphate cement in an amount of 0.03%.
When a mixed composition prepared at a ratio of about 1.5% is used as a calcium phosphate cement, the fluidity of a paste formed by adding a curable aqueous solution thereto is further increased by the action of the magnesium phosphate. Improve,
Naturally, the entrapment of air bubbles is significantly reduced, so that a dense cured body can be formed,
The research result showed that the strength of the formed cured product was significantly improved.

[0005] The present invention has been made based on the above research results, and contains magnesium phosphate: 0.03 to
A living body capable of forming a high-strength cured body, comprising a mixed composition having a composition of 1.5%, dibasic calcium phosphate: 3 to 25%, α-type tribasic calcium phosphate and inevitable impurities: remaining. It is characterized by a calcium phosphate cement for bone reinforcement treatment.

Next, the reason for limiting the composition of the calcium phosphate cement for bone augmentation treatment of the present invention (hereinafter simply referred to as the cement of the present invention) as described above will be described. (A) Magnesium phosphate This component improves the fluidity of the paste during the application of cement as described above, thereby significantly suppressing the entrapment of air bubbles, enabling the formation of a dense cured body, and as a result, It has an effect that contributes to the improvement of the strength of the body, and in order to sufficiently exhibit this effect, in the production of the cement of the present invention, the remaining component α Although it is necessary to mix with the type tribasic calcium phosphate, the ratio is 0.03%
If the ratio is less than 1.5%, the desired effect cannot be obtained. On the other hand, if the ratio exceeds 1.5%, the time required for hardening the cured product increases sharply.
03-1.5%, desirably 0.1-1.0%.

(B) Dibasic calcium phosphate This component has the effect of accelerating the setting of the paste into the cured product, but if its proportion is less than 3%, the desired effect of accelerating the setting cannot be ensured. If the proportion exceeds 25%, the curing is remarkably accelerated, and the workability is impaired. Therefore, the proportion is set to 3 to 25%, preferably 6 to 20%. Examples of the curable aqueous solution of the cement of the present invention include curable aqueous solutions usually used in practice, for example, disodium succinate and sodium chondroitin sulfate, and also sodium lactate, sodium phosphate, sodium chloride, sodium bisulfite, and pyrocarbonate. An aqueous solution containing a predetermined amount of one or more of sodium sulfite and the like, and distilled water can be used.

[0008]

Next, the cement of the present invention will be specifically described with reference to examples. First, as the α-type tribasic calcium phosphate which is a constituent component of the cement of the present invention, the following steps, ie, 3 mol of calcium hydroxide are suspended in 10 l of water, and 2 mol of phosphoric acid is diluted with water. The resulting 40% phosphoric acid aqueous solution was slowly added dropwise with stirring. After completion of the addition, the mixture was allowed to stand at room temperature for 1 day, and then dried using a dryer at 110 ° C. for 24 hours to form aggregates. The agglomerate is held at 1400 ° C. for 3 hours and fired, and the fired product is pulverized and sieved with a sieve by 88 sieves.
α-type tribasic calcium phosphate powder having a purity of 99.9% prepared by adjusting the particle size to μm or less (average particle size: 6.5 μm) was used, and commercially available powders of magnesium phosphate and dicalcium phosphate were used.

First, magnesium phosphate powder and dicalcium phosphate powder among these raw material powders were previously prepared as shown in Table 1.
Is sufficiently kneaded with a kneader for 30 minutes at a ratio corresponding to the total ratio shown in Table 1, and the α-type tricalcium phosphate powder is mixed with the kneaded powder in the mixing ratio shown in Table 1, and mixed to obtain a mixing ratio. The cements 1 to 15 of the present invention and the conventional cements 1 to 8 without the addition of magnesium phosphate were produced by using mixed compositions having substantially the same composition.

Further, for the purpose of evaluating the strength of the hardened bodies formed from the cements 1 to 15 of the present invention and the cements 1 to 8 of the prior art, these cements were each provided with sodium chondroitin sulfate: 5% and disodium succinate / 6.
A hardening aqueous solution containing hydrate: 15%, sodium bisulfite: 0.3%, and the remainder consisting of water was added at a mass ratio of cement: hardening aqueous solution = 3: 1 and kneaded. Into a slurry, and condense this slurry to a diameter of 6 mm.
× height: a cylindrical solidified body dimensions of 12 mm, the solidified ^{body, Na +: 142.0mM, K +} : 5.0mM, Mg
²⁺ : 1.5 mM, Ca ²⁺ : 2.5 mM, Cl ⁻ : 14
8.8 mM, HCO ₃ ⁻ : 4.2 mM, HPO ₄ ²⁻ : 1.
It was immersed and cured in an aqueous solution (simulated body fluid) containing 0 mM for 5 days, and the compressive strength of the cured product after the curing treatment for 5 days was measured. The measurement results are also shown in Table 1.

[0011]

[Table 1]

[0012]

From the results shown in Table 1, the cements 1 to 15 of the present invention in which magnesium phosphate was blended into the mixed composition were used.
It is evident that the hardened body molded from this has a much higher strength than the hardened body formed from the conventional cements 1 to 8 which do not contain the magnesium phosphate.
As described above, the cement of the present invention enables the formation of a hardened body having a high strength, and greatly contributes to the improvement of the strength of a therapeutic reinforcing bone, and can reduce the amount of a hardened body used in industrial applications. They have useful properties.

 ────────────────────────────────────────────────── ─── Continuing on the front page (72) Inventor Nobuyuki Asaoka 2270 Yokoze, Yokoze-cho, Chichibu-gun, Saitama F-term in the Medical Materials Center, Mitsubishi Materials Corporation 4C081 AB04 AB06 CF012 CF022 CF24 DA11 DA13 4C089 AA06 AA13 BA16 CA03 CA07

Claims (1)

[Claims] 1. mass%, magnesium phosphate: 0.03 to 1.5%, dibasic calcium phosphate: 3 to 25%, α-type tribasic calcium phosphate and inevitable impurities: remaining,
A calcium phosphate cement for bone augmentation and treatment of a living body capable of forming a high-strength cured product, characterized by comprising a mixed composition having a composition of: